Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Su TH"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-2 z 2
    Tytuł:
    Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan.
    Autorzy:
    Liu CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
    Liu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
    Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
    Yang HC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
    Hong CM; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
    Tseng TC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
    Chen PJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
    Chen DS; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
    Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2018 Dec 21; Vol. 13 (12), pp. e0209299. Date of Electronic Publication: 2018 Dec 21 (Print Publication: 2018).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Antiviral Agents/*administration & dosage
    Benzimidazoles/*administration & dosage
    Fluorenes/*administration & dosage
    Hepacivirus/*genetics
    Hepatitis C, Chronic/*drug therapy
    Hepatitis C, Chronic/*virology
    Ribavirin/*administration & dosage
    Uridine Monophosphate/*analogs & derivatives
    Adult ; Aged ; Aged, 80 and over ; Antiviral Agents/adverse effects ; Benzimidazoles/adverse effects ; Drug Administration Schedule ; Drug Therapy, Combination ; Female ; Fluorenes/adverse effects ; Genotype ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Ribavirin/adverse effects ; Safety ; Sofosbuvir ; Sustained Virologic Response ; Taiwan ; Treatment Outcome ; Uridine Monophosphate/administration & dosage ; Uridine Monophosphate/adverse effects
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments.
    Autorzy:
    Nien HC; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Liver Disease Prevention and Treatment Research Foundation, Taipei, Taiwan.; Department of Family Medicine, National Taiwan University Hospital, Taipei, Taiwan.
    Hsu SJ; Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin, Taiwan.
    Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
    Yang PJ; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
    Sheu JC; Liver Disease Prevention and Treatment Research Foundation, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
    Wang JT; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
    Chow LP; Graduate Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan.
    Chen CL; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Graduate Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
    Kao JH; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
    Yang WS; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2017 Jan 20; Vol. 12 (1), pp. e0170028. Date of Electronic Publication: 2017 Jan 20 (Print Publication: 2017).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Antiviral Agents/*therapeutic use
    Carrier Proteins/*blood
    Hepatitis C, Chronic/*blood
    Membrane Glycoproteins/*blood
    Acute-Phase Proteins ; Adult ; Biomarkers/blood ; Case-Control Studies ; Female ; Hepatitis C, Chronic/drug therapy ; Humans ; Male ; Middle Aged ; Retrospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-2 z 2

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies